EquityBulls

Latest News

Anand Rayons Ltd receives approval for STAPII trademark
IRFC extends funding support to PVUNL for INR 3,388.51 crore
Zaggle Prepaid Ocean Services Ltd enters into agreement with IDFC First Bank Ltd
PNG Jewellers expands National Footprint, Celebrates Lucknow's Cultural Legacy with Maiden Store Launch
Interarch strengthens presence in Multi-Storey Steel Buildings with new plant in Attivaram, Andhra Pradesh

Keywords Selected: USFDA

Stock Report

Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Paroxetine Extended Release Tablets USP, 25 mg and 37.5 mg.
Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Observations
Lupin gets 4 observations from USFDA from PAI at Pune Biotech facility
USFDA successfully completes inspection at Indoco's API manufacturing facility at Patalganga with zero observations
Lupin receives approval from U.S. FDA for Lenalidomide Capsules
Lupin receives 6 observations from USFDA for Nagpur Injectable facility
Alembic Pharmaceuticals Ltd receives EIR from USFDA for facility at Panelav
Update on US FDA Inspection at Sun Pharma Halol Facility
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe
USFDA conducts product specific pre-approval inspection at Lupin Ltd's Aurangabad facility
Closure of USFDA inspection at Zydus' injectable manufacturing plant at Jarod
U.S. FDA Completes Inspection at Biocon Biologics' Facility at Biocon Campus, Bengaluru, India
Caplin Steriles Ltd granted final approval for ANDA Milrinone Lactate in 5% Dextrose Injection by USFDA
Lupin receives U.S. FDA approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity
Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
SMS Pharmaceuticals Ltd receives EIR from USFDA for Central Laboratory Analytical Services
Unichem Laboratories Ltd receives EIR from USFDA classifying Roha API facility as VAI
Gland Pharma receives approval for Vasopressin in 5% Dextrose RTU Injection
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg
Gland Pharma receives approval for Norepinephrine Bitartrate in 5% Dextrose Injection Bags
Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial
Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg